Erin P. Ward
( out of 45 reviews )

Erin P. Ward, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Salt Lake City
801-587-4415

  • Erin P. Ward, MD is a surgical oncologist who specializes in the treatment of patients with abdominal cancers. She specializes in the surgical management of appendix cancer, neuroendocrine tumors, gastric cancer, and metastatic colorectal cancer. She is an expert in the treatment of peritoneal surface malignancies and other cancers that may have spread to the peritoneal lining, including the use of advanced therapies such as cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

    Dr. Ward is an Assistant Professor at the University of Utah; prior to joining she trained with world-renowned experts at the Medical College of Wisconsin and the University of California San Diego. Dr. Ward grew up in Michigan where she earned her medical degree at the College of Human Medicine at Michigan State University. She completed her general surgery residency and a two-year research fellowship at the University of California San Diego. She completed her training with a two-year Complex Surgical Oncology and completed an AHPBA Certified hepato-pancreatic biliary surgery fellowship at the Medical College of Wisconsin. She is board certified in both general surgery and complex general surgical oncology.

    Dr. Ward is one of two Commission on Cancer Liaison Physicians at the Huntsman Cancer Institute and actively pursuing research to understand better the impact of psychosocial health on cancer patient outcomes and patient-reported outcomes.

    Dr. Ward’s primary research focus is defining the impact of psychosocial health on the long-term and short-term outcomes for cancer patients.

    Dr. Ward’s clinical interests include:

    • Metastatic colorectal cancer
    • Appendiceal cancer
    • Gastric cancer
    • Neuroendocrine tumors
    • Minimally invasive surgery
    • Mesothelioma
    • Peritoneal based malignancies
    • HIPEC

    Specialties

    Board Certification

    American Board of Surgery
    American Board of Surgery (Sub: Complex General Surgical Oncology)

    Patient Rating

    5.0 /5
    ( out of 45 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 11, 2024
    HUNTSMAN CANCER CENTER

    Thank you, for taking time to explain and being sure I understood. That is important to me. I appreciate your honesty as well.

    October 06, 2024
    HUNTSMAN CANCER CENTER

    Very knowledgeable and easy to talk to. She was concerned about my problem. I did not feel rushed at all during the visit.

    September 04, 2024
    HUNTSMAN CANCER CENTER

    The moment Dr. Ward walked into my room I felt a calm sense in the room. Her staff was so kind and made me and my family very comfortable. I was spoke to in a manner that I understood what was happening and what was going to happen. My family was treated with so much respect also.

    July 11, 2024
    HUNTSMAN CANCER CENTER

    Dr. Ward is a gem--she listens carefully and always addresses all concerns to my satisfaction. Dr. War provide comprehensive and compassionate care, even though my case is fairly simple and low-threat.

    June 21, 2024
    HUNTSMAN CANCER CENTER

    Please use my previous comments for this review. Dr. Ward saved my life when no one in Nevada could figure out what was wrong with me!

    June 15, 2024
    HUNTSMAN CANCER CENTER

    I appreciate that Dr. Ward was very honest but compassionate when speaking to me about my health.

    June 09, 2024
    HUNTSMAN CANCER CENTER

    Dr. Ward is knowledgeable, caring and thorough.

    February 24, 2024
    HUNTSMAN CANCER CENTER

    Dr. Ward took her time to explain everything and answer my questions in detail. She is very patient and not rushed.

    February 18, 2024
    HUNTSMAN CANCER CENTER

    Knowledgeable professional and very capable Dr. Would highly recommend.

    See More Patient Comments

  • Erin P. Ward, MD is a surgical oncologist who specializes in the treatment of patients with abdominal cancers. She specializes in the surgical management of appendix cancer, neuroendocrine tumors, gastric cancer, and metastatic colorectal cancer. She is an expert in the treatment of peritoneal surface malignancies and other cancers that may have spread to the peritoneal lining, including the use of advanced therapies such as cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

    Dr. Ward is an Assistant Professor at the University of Utah; prior to joining she trained with world-renowned experts at the Medical College of Wisconsin and the University of California San Diego. Dr. Ward grew up in Michigan where she earned her medical degree at the College of Human Medicine at Michigan State University. She completed her general surgery residency and a two-year research fellowship at the University of California San Diego. She completed her training with a two-year Complex Surgical Oncology and completed an AHPBA Certified hepato-pancreatic biliary surgery fellowship at the Medical College of Wisconsin. She is board certified in both general surgery and complex general surgical oncology.

    Dr. Ward is one of two Commission on Cancer Liaison Physicians at the Huntsman Cancer Institute and actively pursuing research to understand better the impact of psychosocial health on cancer patient outcomes and patient-reported outcomes.

    Dr. Ward’s primary research focus is defining the impact of psychosocial health on the long-term and short-term outcomes for cancer patients.

    Dr. Ward’s clinical interests include:

    • Metastatic colorectal cancer
    • Appendiceal cancer
    • Gastric cancer
    • Neuroendocrine tumors
    • Minimally invasive surgery
    • Mesothelioma
    • Peritoneal based malignancies
    • HIPEC

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Surgical Oncology
    Board Certification
    American Board of Surgery
    American Board of Surgery (Sub: Complex General Surgical Oncology)

    Education history

    Fellowship Complex General Surgical Oncology - Medical College of Wisconsin Fellow
    Hepato-Pancreato-Biliary - Medical College of Wisconsin Fellow
    Chief Resident General Surgery - University of California, San Diego School of Medicine Administrative Chief Resident
    Surgical Oncology - University of California, San Diego School of Medicine Research Fellow
    Residency General Surgery - University of California, San Diego School of Medicine Resident
    Medicine - Michigan State University College of Human Medicine M.D.
    Undergraduate Physiology - Michigan State University B.S.
    Undergraduate Psychology; Specialization in Bioethics, Humanities and Society - Michigan State University B.S.

    Selected Publications

    Journal Article

    1. Ward EP, Vincent-Sheldon S, Tolat P, Kulkarni N, Aldakkak M, Budithi R, Clarke CN, Tsai S, Evans DB, Christians KK (2024). Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy. Surgery. (Read full article)
    2. Ward EP, Okamuro L, Khan S, Hosseini M, Valasek MA, Ronquillo N Jr, Kelly KJ, Veerapong J, Lowy AM, Baumgartner J (2021). Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC. Hum Pathol, 113, 104-110. (Read full article)
    3. Badaracco AG, Ward E, Barback C, Yang J, Wang J, Huang CH, Kim M, Wang Q, Nam S, Delong J, Blair S, Trogler WC, Kummel A (2019). Indocyanine green modified silica shells for colon tumor marking. Appl Surf Sci, 499. (Read full article)
    4. Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL (2019). Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Ann Surg Oncol, 26(13), 4364-4371. (Read full article)
    5. Wang A, Prieto JM, Ward E, Bickler S, Henry M, Kling K, Thangarajah H, Ignacio R Jr (2018). Operative treatment for intussusception: Should an incidental appendectomy be performed? J Pediatr Surg, 54(3), 495-499. (Read full article)
    6. Voss RK, Ward EP, Ojeda-Fournier H, Blair SL (2018). Doppler Ultrasound-Visible SignalMark Microspheres are Better Identified than HydroMARK® Clips in a Simulated Intraoperative Setting in Breast and Lung Tissue. Ann Surg Oncol, 25(12), 3740-3746. (Read full article)
    7. Ward EP, Yang J, Delong JC, Sung TW, Wang J, Barback C, Mendez N, Horgan S, Trogler W, Kummel AC, Blair SL (2018). Identifying lost surgical needles with visible and near infrared fluorescent light emitting microscale coating. Surgery, 163(4), 883-888. (Read full article)
    8. Langness S, Ward E, Halbach J, Lizardo R, Davenport K, Bickler S, Kling K, Thangarajah H, Grabowski J, Fairbanks T (2017). Plasma D-dimer safely reduces unnecessary CT scans obtained in the evaluation of pediatric head trauma. J Pediatr Surg, 53(4), 752-757. (Read full article)
    9. DeLong JC, Ward EP, Lwin TM, Brumund KT, Kelly KJ, Horgan S, Bouvet M (2017). Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism. Surgery, 163(2), 388-392. (Read full article)
    10. Ward EP, Wang A, Thangarajah H, Lazar D, Bickler S, Fairbanks T, Kling KM (2017). Preemptive Ladd Procedure in congenital diaphragmatic hernia and Abdominal Wall defects does not reduce the risk of future volvulus. J Pediatr Surg, 52(12), 1956-1961. (Read full article)
    11. Ward EP, Unkart JT, Bryant A, Murphy J, Blair SL (2017). Influence of Distance to Hospital and Insurance Status on the Rates of Contralateral Prophylactic Mastectomy, a National Cancer Data Base study. Ann Surg Oncol, 24(10), 3038-3047. (Read full article)
    12. Ward EP, Weiss A, Blair SL (2017). Incidence and treatments of DCIS in octogenarians: grade matters. Breast Cancer Res Treat, 165(2), 403-409. (Read full article)
    13. Yang J, Ward E, Sung TW, Wang J, Barback C, Mendez N, Blair S, Trogler WC, Kummel AC (2017). Silica Shells/Adhesive Composite Film for Color Doppler Ultrasound Guided Needle Placement. ACS Biomater Sci Eng, 3(8), 1780-1787. (Read full article)
    14. Yang J, Wang J, Ta CN, Ward E, Barback CV, Sung TW, Mendez N, Blair SL, Kummel AC, Trogler WC (2017). Ultrasound Responsive Macrophase-Segregated Microcomposite Films for in Vivo Biosensing. ACS Appl Mater Interfaces, 9(2), 1719-1727. (Read full article)
    15. Ward EP, Shiavazzi D, Sood D, Marsden A, Lane J, Owens E, Barleben A (2016). Computed Tomography Fractional Flow Reserve Can Identify Culprit Lesions in Aortoiliac Occlusive Disease Using Minimally Invasive Techniques. Ann Vasc Surg, 38, 151-157. (Read full article)
    16. Ward EP, Wang J, Mendez N, Yang J, Barback C, Wang-Rodriguez J, Trogler W, Kummel AC, Blair S (2016). Utilization of iron (III)-doped nanoshells for in vivo marking of nonpalpable tumors using a VX2 rabbit model. Am J Surg, 212(6), 1140-1146. (Read full article)
    17. Robles J, Weiss A, Ward EP, Unkart J, Blair SL (2016). Treatment of Breast Cancer in Women Aged 80 and Older: A Systematic Review. Breast Cancer: Current Research, 1(4).
    18. Weiss A, Lee KC, Romero Y, Ward E, Kim Y, Ojeda-Fournier H, Einck J, Blair SL (2014). Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy. Ann Surg Oncol, 21(10), 3310-6. (Read full article)

    Review

    1. Ward EP, Zeh Iii HJ, Tsai S (2021). Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer. [Review]. Surg Oncol Clin N Am, 30(4), 657-671. (Read full article)
    2. Ward EP, Evans DB, Tsai S (2020). Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective. [Review]. J Surg Oncol, 123(6), 1405-1413. (Read full article)

    Case Report

    1. Weiss A, Ward EP, Baumgartner JM, Lowy AM, Kelly KJ (2018). Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients. World J Surg Oncol, 16(1), 87. (Read full article)
    2. Halbach J, Ward E, Langness S, Davenport K, Bickler SW, Fairbanks T, Kling K (2017). Gallbladder Polyps in Children: A Painful Inflammatory Process. Am Surg, 83(4), e140-142. (Read full article)

    Editorial

    1. Ward EP, Greenbaum A (2024). Exploring the Patient Experience Through Qualitative Methods: The Missing Piece of Cytoreductive Surgery and HIPEC Research. Ann Surg Oncol. (Read full article)
    2. Cortina CS, Ward EP, Kong AL (2021). The consideration for outpatient mastectomy during the COVID-19 global pandemic. Am J Surg, 222(2), 290-291. (Read full article)

  • News & Podcasts

    Huntsman Cancer Institute News

    Podcasts